Conquer Cancer Foundation
23
5
8
12
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
4.3%
1 terminated/withdrawn out of 23 trials
92.3%
+5.8% vs industry average
0%
0 trials in Phase 3/4
42%
5 of 12 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (23)
Liquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Diagnostic: LEOPARD
Role: collaborator
An Open-Label Pilot Intervention Trial to Prevent Diabetes in Prediabetic Adult Survivors of Childhood Cancer
Role: collaborator
Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy
Role: collaborator
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
Role: collaborator
Evaluating a Bidirectional Priming Intervention for Goals-of-care Communication in Oncology
Role: collaborator
Mobile Health App to Promote Participation of Black Women in Breast Cancer Clinical Trials
Role: collaborator
PROmOting Gynecologic Cancer Patients With Frailty to Achieve Functional Recovery
Role: collaborator
ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL
Role: collaborator
Care Transition Intervention for Hospitalized Patients With Advanced Cancer
Role: collaborator
Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians
Role: collaborator
Metastatic Breast Cancer-Specific Prognostic Tool
Role: collaborator
Geriatric-assessment Interventions to Address Functional Deficits in Older Adults w Multiple Myeloma
Role: collaborator
Psychological Intervention For Brain Tumor Caregivers
Role: collaborator
68Ga-PSMA-11 PET for the Diagnosis of Metastatic Castration Resistant Prostate Cancer
Role: collaborator
Perceptions on Expected Outcomes of Immunotherapy in Advanced Cancer Patients With Poor Performance Status
Role: collaborator
Neoadjuvant Atezolizumab in Localized Bladder Cancer
Role: collaborator
MENCORE-2: Audio Recordings to Improve Decision-making in Advanced Prostate Cancer
Role: collaborator
Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer
Role: collaborator
Accuracy of a Mobile Sensor-Based System for the Detection of Chemotherapy Toxicity in Older Adults With Cancer in a Developing Country
Role: collaborator
Validation of Advanced Colorectal Neoplasm Risk Categories in a Prospective Cohort in Mexico
Role: collaborator